CritiTech Particle Engineering Solutions

A US-based multi-service CDMO with particle engineering expertise, CritiTech helps clients move from proof of concept to GMP production using technologies including spray drying and its proprietary Purcision platform for formulating targeted small-molecule therapies. With dedicated cytotoxic and non-cytotoxic facilities, the ability to handle potent compounds, a full suite of analytical services and fill-finish capabilities, the company can advance projects through clinical trials and into commercial production.